PodMed – Week of October 16, 2017
This week’s topics include predicting mortality in those with congestive heart failure, bystander CPR impact, best management of stable COPD, and NOACs and bleeding risk. Program notes: 0:50 NOACs and bleeding risk 1:51 Also taking other medicines increased risk 2:49 Physicians need to know 3:18 Managing people with COPD 4:21 So many more people with […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - October 13, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Chronic Disease Emergency Medicine Heart And Vascular Patient Care PodMed Safety Source Type: podcasts
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
Ischaemic heart disease is the main cause of heart failure, and a leading cause of death. There is an ongoing search for effective treatments, and the use of bone marrow stem cells is a novel therapy that might help. Enca Martin-Rendon from NHS Blood and Transplant and the University of Oxford and others published their Cochrane Review of the topic in April 2014, and she describes the latest evidence in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - April 29, 2014 Category: Journals (General) Authors: The Cochrane Collaboration Tags: Issue 4 to 6, April to June 2014 Source Type: podcasts
#16: LVAD therapy for patients with congestive heart failure
Guest host Dr Margaret Redfield discusses the basics of left ventricular assist devices (LVADs)—as bridge to transplant, destination therapy, and bridge to recovery—with leading heart-failure surgeon Dr Soon Park. What role are LVADs playing in HF? (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - October 10, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
JAMA: 2011-03-02, Vol. 305, No. 9, Author in the Room™ Audio Interview
Interview with Lydia A. Bazzano, MD, PhD, and Angela M. Thompson, authors of Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension: A Meta-analysis. Summary Points: 1. Cardiovascular disease (CVD) risk increases beginning at systolic blood pressure levels of 115 mm Hg and the use of antihypertensive medications among patients with a history of CVD or diabetes and without hypertension have been debated. 2. Among patients with clinical history of CVD but with blood pressure lower than 140/90 mm Hg, antihypertensive treatment was associated with decreased risk...
Source: JAMA Author in the Room - May 19, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2011-03-02, Vol. 305, No. 9, Author in the Room ™ Audio Interview
Interview with Lydia A. Bazzano, MD, PhD, and Angela M. Thompson, authors of Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension: A Meta-analysis. Summary Points: 1. Cardiovascular disease (CVD) risk increases beginning at systolic blood pressure levels of 115 mm Hg and the use of antihypertensive medications among patients with a history of CVD or diabetes and without hypertension have been debated. 2. Among patients with clinical history of CVD but with blood pressure lower than 140/90 mm Hg, antihypertensive treatment was associated with decreased risk...
Source: JAMA Author in the Room - May 19, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
